Telesis Bio Pink Sheet Forward View

TBIO Stock  USD 0.06  0  7.84%   
Telesis Pink Sheet outlook is based on your current time horizon.
As of today, The relative strength index (RSI) of Telesis Bio's share price is at 57. This usually implies that the pink sheet is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Telesis Bio, making its price go up or down.

Momentum 57

 Buy Extended

 
Oversold
 
Overbought
The successful prediction of Telesis Bio's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Telesis Bio, which may create opportunities for some arbitrage if properly timed.
Using Telesis Bio hype-based prediction, you can estimate the value of Telesis Bio from the perspective of Telesis Bio response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Telesis Bio on the next trading day is expected to be 0.07 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.63.

Telesis Bio after-hype prediction price

    
  USD 0.06  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Historical Fundamental Analysis of Telesis Bio to cross-verify your projections.

Telesis Bio Additional Predictive Modules

Most predictive techniques to examine Telesis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Telesis using various technical indicators. When you analyze Telesis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A naive forecasting model for Telesis Bio is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Telesis Bio value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Telesis Bio Naive Prediction Price Forecast For the 1st of February

Given 90 days horizon, the Naive Prediction forecasted value of Telesis Bio on the next trading day is expected to be 0.07 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0004, and the sum of the absolute errors of 0.63.
Please note that although there have been many attempts to predict Telesis Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Telesis Bio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Telesis Bio Pink Sheet Forecast Pattern

Backtest Telesis Bio  Telesis Bio Price Prediction  Buy or Sell Advice  

Telesis Bio Forecasted Value

In the context of forecasting Telesis Bio's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Telesis Bio's downside and upside margins for the forecasting period are 0.0006 and 134.65, respectively. We have considered Telesis Bio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.06
0.0006
Downside
0.07
Expected Value
134.65
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Telesis Bio pink sheet data series using in forecasting. Note that when a statistical model is used to represent Telesis Bio pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria110.1784
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0103
MAPEMean absolute percentage error1.007
SAESum of the absolute errors0.6298
This model is not at all useful as a medium-long range forecasting tool of Telesis Bio. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Telesis Bio. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Telesis Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Telesis Bio. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0652.81
Details
Intrinsic
Valuation
LowRealHigh
0.000.0652.81
Details

Telesis Bio After-Hype Price Density Analysis

As far as predicting the price of Telesis Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Telesis Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Telesis Bio, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Telesis Bio Estimiated After-Hype Price Volatility

In the context of predicting Telesis Bio's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Telesis Bio's historical news coverage. Telesis Bio's after-hype downside and upside margins for the prediction period are 0.00 and 52.81, respectively. We have considered Telesis Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.06
0.06
After-hype Price
52.81
Upside
Telesis Bio is out of control at this time. Analysis and calculation of next after-hype price of Telesis Bio is based on 3 months time horizon.

Telesis Bio Pink Sheet Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Telesis Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Telesis Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Telesis Bio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  28.78 
134.58
  0.09 
 0.00  
2 Events / Month
0 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.06
0.06
9.09 
4,486,000  
Notes

Telesis Bio Hype Timeline

Telesis Bio is at this time traded for 0.06. The entity has historical hype elasticity of -0.09, and average elasticity to hype of competition of 0.0. Telesis is forecasted to increase in value after the next headline, with the price projected to jump to 0.06 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is estimated to be 9.09%, whereas the daily expected return is at this time at 28.78%. The volatility of related hype on Telesis Bio is about 4.486E8%, with the expected price after the next announcement by competition of 0.06. The company has return on total asset (ROA) of (0.2652) % which means that it has lost $0.2652 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4784) %, meaning that it created substantial loss on money invested by shareholders. Telesis Bio's management efficiency ratios could be used to measure how well Telesis Bio manages its routine affairs as well as how well it operates its assets and liabilities. Given the investment horizon of 90 days the next forecasted press release will be in a few days.
Check out Historical Fundamental Analysis of Telesis Bio to cross-verify your projections.

Telesis Bio Related Hype Analysis

Having access to credible news sources related to Telesis Bio's direct competition is more important than ever and may enhance your ability to predict Telesis Bio's future price movements. Getting to know how Telesis Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Telesis Bio may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
CHYPFHealth Logic Interactive 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
PPJEPPJ Healthcare Enterprises 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
CYDXCyduct Diagnostics 0.00 0 per month 0.00  0.12  15.91  0.00  440.74 
CHMEChina Medicine 0.00 0 per month 0.00  0.08  7.69  0.00  90.10 
USPSUltimate Sports 0.00 0 per month 0.00 (0.21) 0.00  0.00  9.09 
ESMCEscalon Medical Corp 0.00 0 per month 2.38 (0) 6.67 (5.88) 19.22 
MAHNMid Atlantic Home Health 0.00 0 per month 0.00  0.11  0.00  0.00  970.91 
EPGNFEpigenomics AG 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
WLSIWellstar International 0.00 1 per month 0.00  0.00  0.00  0.00  0.00 
CATV4Cable Tv Internatio(0.0003)3 per month 13.30  0.08  50.00 (33.33) 150.00 

Other Forecasting Options for Telesis Bio

For every potential investor in Telesis, whether a beginner or expert, Telesis Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Telesis Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Telesis. Basic forecasting techniques help filter out the noise by identifying Telesis Bio's price trends.

Telesis Bio Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Telesis Bio pink sheet to make a market-neutral strategy. Peer analysis of Telesis Bio could also be used in its relative valuation, which is a method of valuing Telesis Bio by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Telesis Bio Market Strength Events

Market strength indicators help investors to evaluate how Telesis Bio pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Telesis Bio shares will generate the highest return on investment. By undertsting and applying Telesis Bio pink sheet market strength indicators, traders can identify Telesis Bio entry and exit signals to maximize returns.

Telesis Bio Risk Indicators

The analysis of Telesis Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Telesis Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting telesis pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Telesis Bio

The number of cover stories for Telesis Bio depends on current market conditions and Telesis Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Telesis Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Telesis Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Telesis Bio Short Properties

Telesis Bio's future price predictability will typically decrease when Telesis Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Telesis Bio often depends not only on the future outlook of the potential Telesis Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Telesis Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding29.8 M
Cash And Short Term Investments19.3 M

Other Information on Investing in Telesis Pink Sheet

Telesis Bio financial ratios help investors to determine whether Telesis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Telesis with respect to the benefits of owning Telesis Bio security.